ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,231 | +10.5% | 330,154 | +17.1% | 0.00% | – |
| Q2 2023 | $448,148 | +121.6% | 281,854 | 0.0% | 0.00% | – |
| Q1 2023 | $202,202 | -38.1% | 281,854 | -50.0% | 0.00% | – |
| Q4 2022 | $326,668 | +21.9% | 563,708 | +100.0% | 0.00% | – |
| Q3 2022 | $268,000 | -20.7% | 281,854 | 0.0% | 0.00% | – |
| Q2 2022 | $338,000 | -85.3% | 281,854 | -84.0% | 0.00% | – |
| Q1 2022 | $2,302,000 | -29.0% | 1,757,495 | -4.5% | 0.00% | – |
| Q4 2021 | $3,240,000 | -27.1% | 1,840,910 | -10.1% | 0.00% | – |
| Q3 2021 | $4,443,000 | -86.7% | 2,047,619 | -78.6% | 0.00% | -100.0% |
| Q2 2021 | $33,510,000 | -35.6% | 9,574,242 | +81.5% | 0.00% | -33.3% |
| Q1 2021 | $51,998,000 | +12.5% | 5,273,650 | +23.7% | 0.00% | 0.0% |
| Q4 2020 | $46,228,000 | -20.2% | 4,264,590 | -24.2% | 0.00% | -25.0% |
| Q3 2020 | $57,962,000 | -20.1% | 5,627,389 | +61.9% | 0.00% | -20.0% |
| Q2 2020 | $72,560,000 | +122.2% | 3,475,116 | +4.0% | 0.01% | +66.7% |
| Q1 2020 | $32,652,000 | -9.2% | 3,342,089 | +7.0% | 0.00% | +50.0% |
| Q4 2019 | $35,974,000 | +36.3% | 3,122,773 | -35.5% | 0.00% | 0.0% |
| Q3 2019 | $26,399,000 | +46.5% | 4,843,777 | +219.5% | 0.00% | +100.0% |
| Q2 2019 | $18,025,000 | +262.4% | 1,516,017 | +59.7% | 0.00% | – |
| Q1 2019 | $4,974,000 | +72.6% | 949,279 | +3.8% | 0.00% | – |
| Q4 2018 | $2,882,000 | -49.0% | 914,765 | -2.1% | 0.00% | – |
| Q3 2018 | $5,652,000 | +22.2% | 933,957 | +7.0% | 0.00% | – |
| Q2 2018 | $4,625,000 | +1613.0% | 872,503 | +1775.1% | 0.00% | – |
| Q1 2018 | $270,000 | +440.0% | 46,532 | +234.6% | 0.00% | – |
| Q4 2017 | $50,000 | -94.4% | 13,908 | -95.8% | 0.00% | – |
| Q1 2017 | $899,000 | -3.7% | 332,173 | +3.4% | 0.00% | – |
| Q4 2016 | $934,000 | -23.4% | 321,273 | +8.1% | 0.00% | – |
| Q3 2016 | $1,220,000 | +31.3% | 297,156 | +1.0% | 0.00% | – |
| Q2 2016 | $929,000 | – | 294,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |